COMP <GO>
CME vs ICE // EV/EBITDA & P/E VALUATION
CME Group Inc. (NASDAQ) VS. Intercontinental Exchange Inc. (NYSE) • 15-METRIC TALLY: CME 7
— ICE 5
▲ EV/EBITDA & P/E VALUATION LEADER: ICE
LAST: $303.14 (+2.27%) • MKT CAP: $106.10B
valuation
40.2x
LAST: $168.85 (+3.56%) • MKT CAP: $91.53B
valuation
20.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CME VS. ICE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CME | ICE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.50% | 8.30% | -4.80 | ICE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 40.2x | 20.8x | +19.40 | ICE | /valuation <GO> |
| Free Cash Flow Yield | 3.95% | 4.69% | -0.74 | ICE | /fcf-yield <GO> |
| Operating Margin | 64.90% | 39.00% | +25.90 | CME | /operating-margins <GO> |
| Net Profit Margin | 62.50% | 26.20% | +36.30 | CME | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | 7.50% | -1.10 | ICE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.71% | 1.21% | +2.50 | CME | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | ICE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.6 | 56.0 | +1.60 | CME | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.89 | +0.12 | CME | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.3x | 25.7x | -1.40 | CME | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $106.10B | $91.53B | $14.57B | CME | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CME REV | ICE REV | CME GROSS % | ICE GROSS % | CME FCF | ICE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.52B | $12.64B | — | — | $4.19B | $4.29B |
| FY 2024 | $6.13B | $11.76B | — | — | $3.60B | $4.20B |
| FY 2023 | $5.58B | $9.90B | — | — | $3.20B | $3.10B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CME // BETA 1.01
ICE // BETA 0.89